Noiruimunbaiotekku
4893.TTSE GROWTHPharmaceutical
Filed as Noile-Immune Biotech Inc. (2023-08–2026-08)
In English · 3
Fri, Oct 9 · JST1 filing
09:245% STAKENoiruimunbaiotekku · OKASAN SECURITIES CO., LTD. · 19.29%new 19.29%Wed, Jul 31 · JST1 filing
16:055% STAKENoiruimunbaiotekku · TSURUKAME CO., LTD + 2 joint holders · 21.90% → 20.63%−1.27ppFri, Jul 26 · JST1 filing
16:055% STAKENoiruimunbaiotekku · TSURUKAME CO., LTD + 2 joint holders · 25.14% → 21.90%−3.24ppAll EDINET filings · 40
| Filed | Document | Source |
|---|---|---|
| 2026-09-18 | Securities registration | S100Z3DF |
| 2026-08-13 | CEO/CFO certification | S100YWIY |
| 2026-03-23 | CEO/CFO certification | S100XSPY |
| 2026-03-23 | Internal control report | S100XSPD |
| 2025-08-08 | CEO/CFO certification | S100WI8U |
| 2025-03-28 | CEO/CFO certification | S100VILR |
| 2025-03-28 | Internal control report | S100VILP |
| 2024-10-15 | Amended CEO/CFO certificationAmends S100U7QY | S100UJBB |
| 2024-08-13 | CEO/CFO certification | S100U7QY |
| 2024-05-14 | CEO/CFO certification | S100TFAV |
| 2024-03-29 | CEO/CFO certification | S100T6Q0 |
| 2024-03-29 | Internal control report | S100T6PW |
| 2023-11-13 | CEO/CFO certification | S100S9GK |
| 2023-06-19 | Amended securities registrationRelated to S100QTTG | S100QZAT |
| 2023-06-12 | Amended securities registrationRelated to S100QTTG | S100QXEI |
| 2023-05-25 | Securities registration | S100QTTG |
EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected.